Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000077023 | SCV000301261 | pathogenic | Breast-ovarian cancer, familial 2 | 2016-09-08 | reviewed by expert panel | curation | Variant allele predicted to encode a truncated non-functional protein. |
Ambry Genetics | RCV000216064 | SCV000277088 | pathogenic | Hereditary cancer-predisposing syndrome | 2015-07-15 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000809840 | SCV000950019 | pathogenic | Hereditary breast and ovarian cancer syndrome | 2018-11-21 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ala2770Profs*7) in the BRCA2 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been reported in individuals in the Leiden Open-source Variation Database (PMID: 21520333). ClinVar contains an entry for this variant (Variation ID: 91506). Loss-of-function variants in BRCA2 are known to be pathogenic (PMID: 20104584). For these reasons, this variant has been classified as Pathogenic. |
Sharing Clinical Reports Project |
RCV000077023 | SCV000108820 | pathogenic | Breast-ovarian cancer, familial 2 | 2009-11-30 | no assertion criteria provided | clinical testing |